Cargando…

Identifying Prognostic Features by Bottom-Up Approach and Correlating to Drug Repositioning

BACKGROUND: Traditionally top-down method was used to identify prognostic features in cancer research. That is to say, differentially expressed genes usually in cancer versus normal were identified to see if they possess survival prediction power. The problem is that prognostic features identified f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wei, Yu, Jian, Lian, Baofeng, Sun, Han, Li, Jing, Zhang, Menghuan, Li, Ling, Li, Yixue, Liu, Qian, Xie, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349868/ https://www.ncbi.nlm.nih.gov/pubmed/25738841 http://dx.doi.org/10.1371/journal.pone.0118672

Ejemplares similares

A Quantitative Analysis of the Impact on Chromatin Accessibility by Histone Modifications and Binding of Transcription Factors in DNase I Hypersensitive Sites
por: Cui, Peng, et al.
Publicado: (2013)

Review of Drug Repositioning Approaches and Resources
por: Xue, Hanqing, et al.
Publicado: (2018)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012)

Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment
por: Li, Yong, et al.
Publicado: (2020)

Identifying Effective Antiviral Drugs Against SARS-CoV-2 by Drug Repositioning Through Virus-Drug Association Prediction
por: Peng, Lihong, et al.
Publicado: (2020)

The assessment of efficient representation of drug features using deep learning for drug repositioning
por: Moridi, Mahroo, et al.
Publicado: (2019)

Old drug repositioning and new drug discovery through similarity learning from drug-target joint feature spaces
por: Zheng, Yi, et al.
Publicado: (2019)

Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19
por: Le, Brian L., et al.
Publicado: (2021)

Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19
por: Le, Brian L., et al.
Publicado: (2021)

Repositioning of Antiparasitic Drugs for Tumor Treatment
por: Li, Yan-Qi, et al.
Publicado: (2021)

Bottom-Up Preparation Techniques for Nanocrystals of Lipophilic Drugs
por: de Waard, Hans, et al.
Publicado: (2010)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Repositioning Drugs for Rare Diseases Based on Biological Features and Computational Approaches
por: Otero-Carrasco, Belén, et al.
Publicado: (2022)

Integrative Analysis of Transcriptional Regulatory Network and Copy Number Variation in Intrahepatic Cholangiocarcinoma
por: Li, Ling, et al.
Publicado: (2014)

In silico drug repositioning based on integrated drug targets and canonical correlation analysis
por: Chen, Hailin, et al.
Publicado: (2022)

An in silico drug repositioning workflow for host-based antivirals
por: Li, Zexu, et al.
Publicado: (2021)

Using Functional Signatures to Identify Repositioned Drugs for Breast, Myelogenous Leukemia and Prostate Cancer
por: Shigemizu, Daichi, et al.
Publicado: (2012)

MULGA, a unified multi-view graph autoencoder-based approach for identifying drug–protein interaction and drug repositioning
por: Ma, Jiani, et al.
Publicado: (2023)

Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks
por: Qin, Shimei, et al.
Publicado: (2023)

Bottom-Up and Top-Down Graph Pooling
por: Yang, Jia-Qi, et al.
Publicado: (2020)

Drug repositioning: A bibliometric analysis
por: Sun, Guojun, et al.
Publicado: (2022)

Transcriptome-based drug repositioning identifies TPCA-1 as a potential selective inhibitor of esophagus squamous carcinoma cell viability
por: Li, Zongyang, et al.
Publicado: (2022)

Pathway-based drug repositioning using causal inference
por: Li, Jiao, et al.
Publicado: (2013)

Bottom-Up Synthesis and Sensor Applications of Biomimetic Nanostructures
por: Wang, Li, et al.
Publicado: (2016)

The Prediction of Drug-Disease Correlation Based on Gene Expression Data
por: Cui, Hui, et al.
Publicado: (2018)

Prognostic genes of melanoma identified by weighted gene co-expression network analysis and drug repositioning using a network-based method
por: Wang, Lu, et al.
Publicado: (2019)

Drug repositioning based on heterogeneous networks and variational graph autoencoders
por: Lei, Song, et al.
Publicado: (2022)

Drug repositioning based on bounded nuclear norm regularization
por: Yang, Mengyun, et al.
Publicado: (2019)

Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017)

Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)

GREP: genome for REPositioning drugs
por: Sakaue, Saori, et al.
Publicado: (2019)

Transcriptome-Guided Drug Repositioning
por: Arakelyan, Arsen, et al.
Publicado: (2019)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

Bottoms up! : a pathologist's essays on medicine and the humanities /
por: Ober, William B., 1920-

Drug repositioning for esophageal squamous cell carcinoma
por: Bennett, Adam N., et al.
Publicado: (2022)

The bottom-up approach to supersymmetry
por: Zichichi, Antonino
Publicado: (1994)

Macroeconomics from the bottom-up /
Publicado: (2011)

Drug repositioning based on network-specific core genes identifies potential drugs for the treatment of autism spectrum disorder in children
por: Gao, Huan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c4rpdnhbc63gvub0fukrpctvos